Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oragenics Inc (NY: OGEN ) 1.530 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EDT, Jun 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.530 Bid (Size) 1.600 (5) Ask (Size) 2.250 (1) Prev. Close 1.530 Today's Range 1.530 - 1.530 52wk Range 1.000 - 7.740 Shares Outstanding 4,480,693 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Wednesday's After-Market Session June 05, 2024 Via Benzinga Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results May 22, 2024 Via Benzinga Performance YTD -77.43% -77.43% 1 Month -50.16% -50.16% 3 Month +10.07% +10.07% 6 Month -69.94% -69.94% 1 Year -50.65% -50.65% More News Read More Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 22, 2024 Via Benzinga OGEN Stock Earnings: Oragenics Reported Results for Q1 2024 May 15, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Intraday Session May 22, 2024 Via Benzinga Gold Down Over 1%; Williams-Sonoma Posts Strong Earnings May 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session May 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 07, 2024 Via Benzinga Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards April 19, 2024 From Oragenics, Inc. Via Business Wire Oragenics, Inc. Files 10K and Provides Company Update April 01, 2024 From Oragenics, Inc. Via Business Wire Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion March 18, 2024 From Oragenics, Inc. Via Business Wire Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion March 05, 2024 From Oragenics, Inc. Via Business Wire Oragenics Announces Closing of Public Offering March 01, 2024 From Oragenics, Inc. Via Business Wire S&P 500 Edges Lower; ADT Posts Upbeat Earnings February 28, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Intraday Session February 28, 2024 Via Benzinga Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 28, 2024 Via Benzinga Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels February 28, 2024 Via Benzinga Topics Stocks Exposures US Equities Dow Dips 200 Points; TJX Posts Upbeat Sales February 28, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is Applied Therapeutics (APLT) Stock Up 59% Today? February 28, 2024 Via InvestorPlace Why Is Integral Ad Science (IAS) Stock Down 29% Today? February 28, 2024 Via InvestorPlace Why Is Oragenics (OGEN) Stock Down 45% Today? February 28, 2024 Via InvestorPlace Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket February 28, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 28, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday February 28, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
